EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis



Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis



Cellular Immunology 99(1): 108-118



We have shown earlier that a decline in splenic natural killer (NK) activity during the development of transplanted or spontaneous tumors in mice results from an inactivation of NK lineage cells, mediated by prostaglandins (primarily PGE2) secreted by NK suppressor cells of the monocyte-macrophage lineage. In the present study we have used a C3H mouse mammary carcinoma model to examine whether this mechanism of NK suppression is conducive to tumor metastasis in vivo and whether a reversal of this suppression by a chronic indomethacin therapy can prevent metastatic spread from the primary tumor site. Three mammary tumor lines, all derived in our laboratory from a spontaneous C3H mammary tumor were employed: T-58 (uncloned parental line, having weak lung metastasizing ability from the subcutaneous site), C3 (a clone of T-58, showing high metastatic ability), and C10 (a nonmetastatic clone of T-58). Although the degree of NK susceptibility of these lines varied inversely with their metastatic potential, none was NK resistant. A chronic administration of indomethacin in the drinking water (14 micrograms/ml) to mice beginning on Day 4 after subcutaneous transplantation of 10(6) tumor cells resulted in a significant reduction in the growth rate of primary tumors in all hosts and led to a complete or nearly complete abrogation of lung metastasis in T-58- or C3-transplanted hosts examined at 1 month after tumor transplantation; C10-transplanted mice showed no metastasis in the control or the treated group. Concomitantly, there was a substantial restoration of splenic NK activity in all indomethacin-treated hosts. Plastic-adherent cells (greater than 95% macrophages) isolated from tumors growing in control mice, when coincubated for 20 hr with normal splenic effector cells caused a suppression of NK activity, reversible in the presence of indomethacin (10(-5) M) in vitro. Similar cells recovered from the residual primary tumors in indomethacin-treated mice had no suppressor ability. Chemically pure PGE2 (at concentrations of 0.5 to 1 X 10(-6) M, but not 0.25 X 10(-6) to 10(-8) M) also caused a suppression of NK activity of normal splenic effector cells, when added during the 4-hr 51Cr-release assay or allowed to interact with effector cells alone for a 20-hr incubation period; a removal of the cell-free PGE2 in the latter case prior to the NK assay did not relieve the suppression.(ABSTRACT TRUNCATED AT 400 WORDS)

(PDF same-day service: $19.90)

Accession: 040416977

Download citation: RISBibTeXText

PMID: 2944621

DOI: 10.1016/0008-8749(86)90220-0



Related references

Indomethacin therapy abrogates prostaglandins mediated suppression of natural killer activity and prevents metastasis in tumor bearing mice. Anatomical Record: 70a, 1986

Indomethacin therapy relieves prostaglandin mediated suppression of natural killer activity and prevents lung metastasis in tumor bearing mice. Federation Proceedings 45(3): 621, 1986

Prostaglandin mediated suppression of natural killer cells and its relevance to tumor metastasis. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 349, 1986

Indomethacin inhibits kidney metastasis in bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro. Anticancer Research 18(5a): 3549-3554, 1998

Prostaglandin E2-mediated suppression of murine lymphokine-activated killer cell activity generated from tumor-bearing hosts by interferon-gamma. Molecular BioTherapy 2(4): 228-232, 1990

Interferon therapy and natural killer activity in intracranial tumor-bearing mice. Nihon Geka Hokan. Archiv für Japanische Chirurgie 52(1): 67-71, 1983

Suppression of the activity of natural killer-like cells by peritoneal macrophages obtained from Lewis lung tumor-bearing, Propionibacterium granulosum KP-45-treated, or normal, untreated mice. Immunobiology 176(1-2): 73-84, 1987

Changes in the host natural killer cell population in mice during tumor development 2. the mechanism of suppression of natural killer activity. Cellular Immunology 93(2): 265-279, 1985

Beta-glucosylceramide administration (i.p.) activates natural killer T cells in vivo and prevents tumor metastasis in mice. Lipids 47(6): 581-591, 2012

The thymus in mice bearing the lewis lung carcinoma 1. thymic natural killer cell activity in 3ll tumor bearing mice. Cellular Immunology 80(1): 187-197, 1983

Studies of the thymus in mice bearing the Lewis lung carcinoma. I. Thymic natural killer cell activity in 3LL tumor-bearing mice. Cellular Immunology 80(1): 187-197, 1983

Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets. European Journal of Immunology 31(9): 2818-2828, 2001

Host mediated immune suppression in tumor bearing mice in vitro reversal by indomethacin or removal of adherent cells. Federation Proceedings 37(6): 1451, 1978

Natural killer activity in tumor bearing mice. Journal of Cellular Biochemistry Supplement (6): 28, 1982

Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. Journal of Immunology 130(2): 974-980, 1983